Drugs / Vaginal estrogen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT01648751 | May 2012 → Mar 2023 | pelvic organ prolapse | Pamela Moalli | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03996057 Background | Jun 2018 → Feb 2022 | female reproductive system disorder, urinary tract infection | Washington University School of Medicine | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaginal estrogen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03996057 ↗ |